Land: Malaysia
Sprog: engelsk
Kilde: NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)
noradrenaline tartrate
EUCOGEN SDN BHD
noradrenaline tartrate
10 ampoules x 4 ml
HBM PHARMA S.R.O.
Font size 11 pt, as measure in Times New Roman SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE MEDICINAL PRODUCT Norepinephrine Kalceks 1 mg/ml concentrate for solution for infusion 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each 1 ml of concentrate for solution for infusion contains norepinephrine tartrate equivalent to 1 mg norepinephrine. Each ampoule containing 4 ml of concentrate for solution for infusion contains norepinephrine tartrate equivalent to 4 mg norepinephrine. When diluted as recommended, each ml contains norepinephrine tartrate equivalent to 4 micrograms norepinephrine. For the full list of excipients, see section 6.1. 3. PHARMACEUTICAL FORM Concentrate for solution for infusion (sterile concentrate). Clear, colourless or yellowish solution, practically free from visible particles. Description after dilution: Clear, colourless or yellowish solution, practically free from visible particles. 4. CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS For blood pressure control in certain acute hypotensive states (e.g. pheochromocytomectomy, sympathectomy, poliomyelitis, spinal anaesthesia, myocardial infarction, septicaemia, blood transfusion, and drug reactions). As an adjunct in the treatment of cardiac arrest and profound hypotension. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION _Restoration of blood pressure in acute hypotensive state:_ Blood volume depletion should always be corrected as fully as possible before any vasopressor is administered. When, as an emergency measure, intra-aortic pressures must be maintained to prevent cerebral or coronary artery ischemia, norepinephrine can be administered before and concurrently with blood volume replacement. _Diluent: _ Norepinephrine Kalceks should be diluted in glucose 50 mg/ml (5%) or sodium chloride 9 mg/ml (0.9%) with glucose 50 mg/ml (5%) solution for injection. These glucose containing fluids are protection against significant loss of potency due to oxidation. Administration in saline solution alone is not recommended. Whole blood or plasma, if indi Læs hele dokumentet